MYC and osteosarcoma: In the same cell contexts, we also tested Tigecycline, another tetracycline that was recently shown to curb proliferation of MYC-overexpressing lymphoma and osteosarcoma cells [7, 10], but we did not achieve the anti-proliferative effects of doxycycline (data not shown).